KSI vs. VHI, FRX, DR, OGI, QIPT, CPH, MDNA, ACB, CRDL, and HLS
Should you be buying kneat.com stock or one of its competitors? The main competitors of kneat.com include Vitalhub (VHI), Fennec Pharmaceuticals (FRX), Medical Facilities (DR), Organigram (OGI), Quipt Home Medical (QIPT), Cipher Pharmaceuticals (CPH), Medicenna Therapeutics (MDNA), Aurora Cannabis (ACB), Cardiol Therapeutics (CRDL), and HLS Therapeutics (HLS). These companies are all part of the "medical" sector.
Vitalhub (TSE:VHI) and kneat.com (TSE:KSI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment, earnings and community ranking.
Vitalhub presently has a consensus target price of C$7.25, indicating a potential upside of 1.83%. Given kneat.com's higher probable upside, equities analysts clearly believe Vitalhub is more favorable than kneat.com.
Vitalhub has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500. Comparatively, kneat.com has a beta of 1.01, meaning that its stock price is 1% more volatile than the S&P 500.
In the previous week, Vitalhub had 3 more articles in the media than kneat.com. MarketBeat recorded 10 mentions for Vitalhub and 7 mentions for kneat.com. Vitalhub's average media sentiment score of 0.64 beat kneat.com's score of -0.16 indicating that kneat.com is being referred to more favorably in the news media.
Vitalhub has higher revenue and earnings than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.
16.9% of Vitalhub shares are owned by institutional investors. Comparatively, 11.1% of kneat.com shares are owned by institutional investors. 18.4% of Vitalhub shares are owned by company insiders. Comparatively, 24.7% of kneat.com shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Vitalhub has a net margin of 8.66% compared to Vitalhub's net margin of -41.26%. kneat.com's return on equity of 5.78% beat Vitalhub's return on equity.
Vitalhub received 5 more outperform votes than kneat.com when rated by MarketBeat users. However, 100.00% of users gave kneat.com an outperform vote while only 66.67% of users gave Vitalhub an outperform vote.
Summary
Vitalhub beats kneat.com on 13 of the 17 factors compared between the two stocks.
Get kneat.com News Delivered to You Automatically
Sign up to receive the latest news and ratings for KSI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
kneat.com Competitors List
Related Companies and Tools
